Hyperuricemia and Its Complications

Clinical Manifestations

Recurrent episodes of acute inflammatory arthritis characterized by severe joint pain, erythema, swelling, limited range of motion, and commonly affects the first metatarsophalangeal joint, with progression to polyarticular involvement over time 1
Development of tophi (monosodium urate crystal deposits) in joints, soft tissues, and visible as firm, whitish nodules under the skin 1, 2
Chronic joint symptoms due to persistent synovitis, leading to decreased functional capacity and mobility 1
Elevated inflammatory markers due to monosodium urate crystal-induced activation of inflammatory pathways 1

Urolithiasis (kidney stones) due to uric acid crystal formation 1
Progressive renal dysfunction leading to chronic kidney disease, with increased risk in patients with severe hyperuricemia (>9 mg/dL) 3
Elevated cardiovascular morbidity and mortality, with hyperuricemia as an independent risk factor for developing hypertension 4
Poor prognosis in heart failure patients with hyperuricemia, independent of other risk factors 4
Increased mortality risk in patients with heart failure and hyperuricemia 4

Progression from asymptomatic hyperuricemia to symptomatic gout in approximately 20% of patients with serum urate >9 mg/dL within 5 years 3
Evolution from intermittent flares to chronic arthropathy, with increasing frequency and severity of gout attacks over time 1, 2
Patients with severe hyperuricemia (>9 mg/dL) are at particularly high risk for developing clinical sequelae, including cardiovascular and renal disease 3
The presence of comorbidities such as hypertension, obesity, metabolic syndrome, and type 2 diabetes increases the risk of developing gout in patients with hyperuricemia 1

The American College of Rheumatology defines hyperuricemia as elevated blood uric acid levels above normal values (generally >6.8 or 7.0 mg/dL) 1
The gold standard for diagnosis is the identification of monosodium urate crystals in synovial fluid using polarized light microscopy 5
The European League Against Rheumatism recommends that asymptomatic hyperuricemia generally does not require pharmacological treatment, while gout does 1
The treatment goal is to maintain uric acid levels below 6 mg/dL to prevent crystal formation, with a more stringent goal (<5 mg/dL) recommended for severe cases 6
The American College of Rheumatology suggests lifestyle and dietary changes, such as reducing red meat, sugar, and alcohol consumption, and increasing vegetable, water, and vitamin C intake 1
In patients with chronic kidney disease, hyperuricemia is common due to decreased uric acid excretion, and diuretics, especially thiazides and loop diuretics, can contribute to hyperuricemia in elderly patients 6

Untreated gout can progress to chronic arthritis with permanent joint damage 2
Gout is associated with an increased risk of renal and cardiovascular complications 1
Hyperuricemia can be asymptomatic, but not all patients with hyperuricemia develop gout, with approximately 22% of asymptomatic patients with uric acid levels above 9 mg/dL developing gout within 5 years 5